Skip to content

Evaluation of Food Additive Contributions to Obesity - Feasibility Study 3

Evaluation of Food Additive Contributions to Obesity - Feasibility Study 3

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04236713
Enrollment
10
Registered
2020-01-22
Start date
2020-01-24
Completion date
2021-10-15
Last updated
2020-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The effects of food additives on body weight in humans are largely unknown. This is a feasibility study in 10 obese adults who will be followed for 5 months. Eligible participants will be non-randomly assigned to 2 groups and will be taught how to limit the exposure to the studied food additives in their diet. Primary outcomes in this study are recruitment rate, retention rate and adherence to the proposed dietary intervention.

Interventions

Limiting dietary exposure to ethylenediaminetetraacetic acid, erythorbate, propionate and related food additives; limiting eating out to a maximum of 2 days per week.

Limiting dietary exposure to nitrites, sulfites and related food additives; limiting eating out to a maximum of 2 days per week; limiting drinking wine to a maximum of 2 days per week.

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* BMI \>/=30 kg/m2 * willingness and ability to follow the proposed dietary interventions * informed consent

Exclusion criteria

* previous or planned bariatric surgery in the next 1 year * current or planned participation in any structured weight-loss programs in the next 6 months * current or recent (within the last 6 months) use of weight-loss-inducing drugs or systemic steroids * excessive alcohol consumption * bipolar disorder or attention deficit hyperactivity disorder * current use of anti-depressant or anti-psychotic medications * eating disorder or any other active disorder that may lead to significant weight changes * pregnancy or planned pregnancy in the next 1 year * uncontrolled diabetes mellitus or diabetes requiring treatment with \>2 oral diabetes medications or with insulin

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate0 monthsAverage number of participants recruited per month
Retention rate in arm 15 monthsPercent of enrolled participants who complete the study
Retention rate in arm 25 monthsPercent of enrolled participants who complete the study
Adherence to the dietary intervention in arm 12 to 5 monthsProportion of meals/beverages free of the studied food additives on 3 unannounced 24-hour dietary recalls
Adherence to the dietary intervention in arm 22 to 5 monthsProportion of meals/beverages free of the studied food additives on 3 unannounced 24-hour dietary recalls

Countries

Canada

Contacts

Primary ContactNatalia McInnes
natalia.mcinnes@mcmaster.ca905-521-2100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026